Healthmark Industries is proud to announce Dr. Bradley Catalone as their new Senior Scientific Advisor. “We are very excited to welcome Brad to Healthmark Industries,” says Director of Education, Mary Ann Drosnock. “His expert knowledge and management experience in scientific and regulatory device strategy will provide guidance and insight to our product development efforts.”
Dr. Catalone comes to Healthmark Industries with extensive experience in the healthcare industry. Most recently, Brad was the Chief Science Officer at TSO3 Corporation. In this role, he had the responsibility of successfully developing regulatory strategy for new and expanded medical device claims, designing scientific studies and managing/expanding international intellectual property portfolio.
Brad’s healthcare career spans more than 25 years across both commercial and R&D operations, including product development, manufacturing, quality, and clinical affairs. He holds a Ph.D. in Microbiology and Immunology from Penn State College of Medicine, and an MBA from The Pennsylvania State University.
Editor's note: this press release originally appeared on Healthmark's website.
Visit www.hmark.com or call 800-521-6224 for more information.
About Healthmark Industries Co., Inc.
Since 1969, Healthmark Industries Company, Inc. has developed and marketed innovative solutions to aid healthcare facilities in their delivery of surgical instruments and other lifesaving medical devices to patients. Healthmark Industries mission is to continue to innovate, continue to support and continue to serve the healthcare provider industry and support services that make it possible to deliver quality healthcare. Visit www.hmark.com for more information.